Improving neuraminidase content of influenza vaccines is a major focus of vaccine development. Here the authors present safety and immunogenicity of seasonal influenza mRNA vaccine candidates simultaneously encoding hemagglutinin and neuraminidase antigens in a first in-human study.
- Amanda K. Rudman Spergel
- Ivan T. Lee
- Raffael Nachbagauer
